viewBATM Advanced Communications Ltd

Full interview: First commercial order for BATM subsidiary Ador

BATM Advanced Communications Ltd, (LON:BVC) says that Ador Diagnostics, the firm’s subsidiary focused on the development and marketing of unique in-vitro molecular diagnostics solutions, has received its first commercial order from a leading Italian distributor of molecular biology and genomics products. Dr. Zvi Marom speaks to Proactive London about the deal and why it's a 'milestone' for the company.
News here too on how first models of the meningitis test (called NATlab) will go into final trials in leading hospitals in the first half of this year.

Quick facts: BATM Advanced Communications Ltd

Price: 41.5 GBX

Market: LSE
Market Cap: £182.72 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BATM Advanced Communications Ltd named herein, including the promotion by the Company of BATM Advanced Communications Ltd in any Content on the...



Morning Report: European airlines hammered over coronavirus outbreak

Headlines from the Proactive UK newsroom. Coronavirus is causing chaos among European airlines this morning. Wizzair (LON:WIZZ), easyJet (LON:EZJ) and Jet2 owner Dart Group (LON:DTG) are all down by up to 8-10% following the major outbreak in Italy at the weekend. ReNeuron (LON:RENE) has...

2 hours, 34 minutes ago

2 min read